In a study published in 2014 in a mouse xenograft model of human endometriosis, PAR-2 inhibitor ENMD-1068 dose-dependently inhibited endometriotic lesion development and IL-6 and NF-κβ expression [40]. Here, NFKB1 is linked to endometriosis.